Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Orthofix International N.V. to Contact the Firm -- OFIX

NEW YORK, Aug. 16, 2013 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Orthofix International N.V. ("Orthofix" or the "Company") (Nasdaq:OFIX) of the October 15, 2013 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain executives.

A complaint has been filed on behalf of all persons who purchased Orthofix common stock between May 5, 2011 and July 29, 2013 (the "Class Period").

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies. Specifically, the action alleges that: (i) certain revenues should not have been recognized during 2011 and 2012; and as a result (ii) the Company issued materially false and misleading financial statements during the Class Period.

On July 29, 2013, Orthofix announced that it was postponing the release of its financial results for the second quarter of 2013 and its previously announced conference call. The Company explained that additional time was needed to review matters relating to revenue recognition practices for prior periods, and the Audit Committee, along with help from outside professionals, had commenced an internal investigation into these issues.

Following this news, on July 30, 2013, Orthofix's stock dropped $4.46 or 16.28% to close at $22.94. Further, on August 6, 2013, the Company announced that it would restate financial statements for fiscal years 2011 and 2012 and the first quarter of 2013.

Request more information now by clicking here: www.faruqilaw.com/OFIX. There is no cost or obligation to you.

Take Action

If you invested in Orthofix stock or options between May 5, 2011 and July 29, 2013 and would like to discuss your legal rights, visit www.faruqilaw.com/OFIX. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Orthofix's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

CONTACT: FARUQI & FARUQI, LLP
         369 Lexington Avenue, 10th Floor
         New York, NY 10017
         Attn:  Richard Gonnello, Esq.
         rgonnello@faruqilaw.com
         Francis McConville, Esq.
         fmcconville@faruqilaw.com
         Telephone: (877) 247-4292 or (212) 983-9330